Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3977384 | Brachytherapy | 2010 | 8 Pages |
Abstract
The HDR brachytherapy and IMRT yielded similar biochemical disease-free survival and toxicity to IMRT alone. As a result, we continue to base treatment on physician and patient preference. Longer followup will help to determine the role of HDR brachytherapy and IMRT in the treatment of early stage prostate cancer, particularly because a number of patients received androgen deprivation therapy and we delivered a higher biologically effective dose with combined modality therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Richard B. Wilder, Greg A. Barme, Ronald F. Gilbert, Richard E. Holevas, Luis I. Kobashi, Richard R. Reed, Ronald S. Solomon, Nancy L. Walter, Lucy Chittenden, Albert V. Mesa, Jeffrey K. Agustin, Jessica Lizarde, Jorge C. Macedo, John Ravera,